Literature DB >> 11709110

Erosive osteoarthritis: presentation, clinical pearls, and therapy.

G E Ehrlich1.   

Abstract

Erosive osteoarthritis (OA) is a subcategory of OA in which destructive changes occur in the joints, probably as a result of a combination of inflammatory inciters and phenomena. The major changes occur in the distal and proximal interphalangeal joints, root joints of the thumb, and less commonly other hand and centripetal joints. A familial tendency suggests hereditary predisposition, and women more likely to be afflicted than men. Diagnosis has been enhanced by newer imaging techniques such as sonography and scintigraphy. Treatment remains chiefly palliative, although there are hints that alleviation of inflammation may be more salutary than simple analgesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709110     DOI: 10.1007/s11926-001-0062-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  41 in total

1.  Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis. Results of a two-year study.

Authors:  M Olejárová; K Kupka; K Pavelka; J Gatterová; J Stolfa
Journal:  Joint Bone Spine       Date:  2000       Impact factor: 4.929

Review 2.  COX-2 inhibition: an advance or only pharmaceutical "hype"?

Authors:  L S Simon
Journal:  Arthritis Rheum       Date:  2001-06

3.  Evidence for genetic anticipation in nodal osteoarthritis.

Authors:  G D Wright; M Regan; C M Deighton; G Wallis; M Doherty
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Erosive osteoarthritis.

Authors:  K L Kidd; J B Peter
Journal:  Radiology       Date:  1966-04       Impact factor: 11.105

Review 5.  Novel strategies for the treatment of osteoarthritis.

Authors:  I Chikanza; L Fernandes
Journal:  Expert Opin Investig Drugs       Date:  2000-07       Impact factor: 6.206

6.  Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study.

Authors:  K P Günther; T Stürmer; S Sauerland; I Zeissig; Y Sun; S Kessler; H P Scharf; H Brenner; W Puhl
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

7.  Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.

Authors:  G Keyszer; I Lambiri; R Nagel; C Keysser; M Keysser; E Gromnica-Ihle; J Franz; G R Burmester; K Jung
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

8.  The impact of hemiparalysis on the expression of osteoarthritis.

Authors:  R Segal; E Avrahami; E Lebdinski; B Habut; A Leibovitz; I Gil; M Yaron; D Caspi
Journal:  Arthritis Rheum       Date:  1998-12

9.  Relation between Heberden's nodes and distal interphalangeal joint osteophytes and their role as markers of generalised disease.

Authors:  F M Cicuttini; J Baker; D J Hart; T D Spector
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

Review 10.  Angiogenesis in the pathogenesis of inflammatory joint and lung diseases.

Authors:  D A Walsh; C I Pearson
Journal:  Arthritis Res       Date:  2001-02-23
View more
  9 in total

Review 1.  An autumn tale: geriatric rheumatoid arthritis.

Authors:  Senol Kobak; Cemal Bes
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-07       Impact factor: 5.346

2.  Differences of radiocarpal cartilage alterations in arthritis and osteoarthritis using morphological and biochemical magnetic resonance imaging without gadolinium-based contrast agent administration.

Authors:  Valentina Mori; Lino M Sawicki; Philipp Sewerin; Markus Eichner; Benedikt M Schaarschmidt; Lisa Oezel; Sebastian Gehrmann; Bernd Bittersohl; Gerald Antoch; Christoph Schleich
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315

3.  [Therapeutic strategies in erosive digital polyarthrosis].

Authors:  E Sahinbegovic; G Schett
Journal:  Internist (Berl)       Date:  2011-06       Impact factor: 0.743

4.  Distinguishing erosive osteoarthritis and calcium pyrophosphate deposition disease.

Authors:  Bruce M Rothschild
Journal:  World J Orthop       Date:  2013-04-18

5.  MR imaging of erosions in interphalangeal joint osteoarthritis: is all osteoarthritis erosive?

Authors:  A J Grainger; J M Farrant; P J O'Connor; A L Tan; S Tanner; P Emery; D McGonagle
Journal:  Skeletal Radiol       Date:  2007-05-12       Impact factor: 2.199

Review 6.  Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy.

Authors:  Juan Ignacio Villa-Blanco; Jaime Calvo-Alén
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

7.  Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study.

Authors:  Antonella Fioravanti; Marta Fabbroni; Alfonso Cerase; Mauro Galeazzi
Journal:  Rheumatol Int       Date:  2009-02-06       Impact factor: 2.631

Review 8.  Nerve growth factor: an update on the science and therapy.

Authors:  M F Seidel; B L Wise; N E Lane
Journal:  Osteoarthritis Cartilage       Date:  2013-09       Impact factor: 6.576

Review 9.  Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities.

Authors:  Reza Mohammadinejad; Milad Ashrafizadeh; Abbas Pardakhty; Ilona Uzieliene; Jaroslav Denkovskij; Eiva Bernotiene; Lauriane Janssen; Gabriela S Lorite; Simo Saarakkala; Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2020-04-04       Impact factor: 4.592

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.